Curated News
By: NewsRamp Editorial Staff
October 07, 2024
Former Senior Advisor to Obama Joins Forces with Innovative Biotech
Discuss on Reddit
Discuss on LinkedIn
Discuss on SubstackTLDR
- Investors in Mainz Biomed (NASDAQ: MYNZ) gain advantage in the market with life-saving medical innovations.
- Mainz Biomed's clinical laboratory tests enable early detection and prevention of disease, saving costs and lives.
- Medical innovations from Mainz Biomed lead to longer lives and better health for patients, making the world a better place.
- Former senior advisor to President Obama and rectal cancer survivor, Petra Smeltzer Starke, is the new face of Mainz Biomed.
Impact - Why it Matters
This news matters because it highlights the collaboration between a prominent figure and a biotech company to promote early detection of diseases, potentially impacting the lives of many patients. The interview with Petra Smeltzer Starke sheds light on the importance of clinical laboratory tests in saving lives.
Summary
Petra Smeltzer Starke, Brand Ambassador for Mainz Biomed (NASDAQ: MYNZ), discusses the company's clinical laboratory tests that enable early detection and prevention of disease, leading to longer and healthier lives for patients. As a former senior advisor to President Obama and a cancer survivor, Starke is uniquely suited to help spread the word about early detection and save lives.
Watch the full interview here:
Featured photo by Louis Reed on Unsplash.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Former Senior Advisor to Obama Joins Forces with Innovative Biotech
